Publication | Open Access

Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studies

OncologyMedicinePathologyBrca1-rap80 Expression CustomizationBiomarker-directed Randomized TrialsBronchial NeoplasmCancer GenomicsCancer GeneticsMolecular DiagnosticsRadiation OncologyLung CancerCancer ResearchChinese Patients